We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
144 hedge funds and large institutions have $206M invested in Anavex Life Sciences in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 44 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
65% more call options, than puts
Call options by funds: $9.63M | Put options by funds: $5.85M
21% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 14
2% more funds holding
Funds holding: 141 → 144 (+3)
7% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 44
3.47% less ownership
Funds ownership: 34.74% → 31.27% (-3.5%)
11% less capital invested
Capital invested by funds: $232M → $206M (-$25.9M)
Holders
144
Holders Change
+3
Holders Change %
+2.13%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
47
Reduced
44
Closed
14
Calls
$9.63M
Puts
$5.85M
Net Calls
+$3.78M
Net Calls Change
-$3.13M
Top Buyers
| 1 |
Jane Street
New York
|
+$3.54M |
| 2 |
BlackRock
New York
|
+$1.73M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.61M |
| 4 |
Millennium Management
New York
|
+$1.45M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$766K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$10.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.95M |
| 3 |
Goldman Sachs
New York
|
-$3.01M |
| 4 |
Citigroup
New York
|
-$2.18M |
| 5 |
Two Sigma Advisers
New York
|
-$1.32M |
